Kathleen Golebiewski
Advertisement
Articles by Kathleen Golebiewski
Advertisement
Latest Updated Articles
Duvelisib for Relapsed or Refractory CLL/SLLJanuary 22nd 2019
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026
2
PBM Network Terminations Bring Risks Beyond Lost Contracts | NCPA 2026
3
FAQ: Scaling Pharmacy Services Through GLP-1 Care | NCPA 2026
4
Pharmacists Step Up on Test-To-Treat This American Pharmacist Month
5